Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
DOI:
https://doi.org/10.2340/00015555-3693Keywords:
atopic dermatitis, ectodysplasin A, hypohidrotic ectodermal dysplasia, JAK inhibitor, tofacitinibAbstract
Abstract is missing (Short communication)
Downloads
References
Trzeciak WH, Koczorowski R. Molecular basis of hypohidrotic ectodermal dysplasia: an update. J Appl Genet 2016; 57: 51-61.
DOI: https://doi.org/10.1007/s13353-015-0307-4
Zeng B, Lu H, Xiao X, Zhou L, Lu J, Zhu L, et al. Novel EDA mutation in X-linked hypohidrotic ectodermal dysplasia and genotype-phenotype correlation. Oral Dis 2015; 21: 994-1000.
DOI: https://doi.org/10.1111/odi.12376
Nguyen-Nielsen M, Skovbo S, Svaneby D, Pedersen L, Fryzek J. The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010. Eur J Med Genet 2013; 56: 236-242.
DOI: https://doi.org/10.1016/j.ejmg.2013.01.012
Han Y, Wang X, Zheng L, Zhu T, Li Y, Hong J, et al. EDA pathogenic mutations in Chinese Han families with hypohidrotic ectodermal dysplasia and genotype-phenotype: a correlation analysis. Front Genet 2020; 11: 21.
DOI: https://doi.org/10.3389/fgene.2020.00021
Kere J, Srivastava AK, Montonen O, Zonana J, Thomas N, Ferguson B, et al. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet 1996; 13: 409-416.
DOI: https://doi.org/10.1038/ng0895-409
Clarke A, Phillips DI, Brown R, Harper PS. Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child 1987; 62: 989-996.
DOI: https://doi.org/10.1136/adc.62.10.989
Burger K, Schneider AT, Wohlfart S, Kiesewetter F, Huttner K, Johnson R, et al. Genotype-phenotype correlation in boys with X-linked hypohidrotic ectodermal dysplasia. J Med Genet A 2014; 164A: 2424-2432.
DOI: https://doi.org/10.1002/ajmg.a.36541
D'Assante R, Fusco A, Palamaro L, Giardino G, Gallo V, Cirillo E, et al. Unraveling the link between ectodermal disorders and primary immunodeficiencies. Int Rev Immunol 2016; 35: 25-38.
More CB, Bhavsar K, Joshi J, Varma SN, Tailor M. Hereditary ectodermal dysplasia: a retrospective study. J Nat Sci Biol Med 2013; 4: 445-450.
DOI: https://doi.org/10.4103/0976-9668.117012
Miyake T, Kiniwa Y, Kosho T, Nakano H, Okuyama R. Hypohidrotic ectodermal dysplasia: A report of two cases. J Dermatol 2017; 44: 479-481.
DOI: https://doi.org/10.1111/1346-8138.13479
Mark BJ, Becker BA, Halloran DR, Bree AF, Sindwani R, Fete MD, et al. Prevalence of atopic disorders and immunodeficiency in patients with ectodermal dysplasia syndromes. Ann Allergy Asthma Immunol 2012; 108: 435-438.
DOI: https://doi.org/10.1016/j.anai.2012.04.010
Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, et al. Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol 2016; 175: 902-911.
DOI: https://doi.org/10.1111/bjd.14871
Levy LL, Urban J, King BA. Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate. J Am Acad Dermatol 2015; 73: 395-399.
DOI: https://doi.org/10.1016/j.jaad.2015.06.045
Guttman-Yassky E, Silverberg JI, Nemoto O, Forman SB, Wilke A, Prescilla R, et al. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. J Am Acad Dermatol 2019; 80: 913-921.e919
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Xiangqian Li, Xia Wu, Dirk M. Elston, Jianzhong Zhang, Cheng Zhou
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
